IL6 and depressive symptom measurement: In a systematic review and exploratory meta-analyses in which levels of neurotrophic, inflammatory and oxidative stress biomarkers were analyzed in combination as a function of an affective state (euthymia, mania, depression), no biomarkers were found that could be individually discriminative of each mood phase, with the combination of hsCRP/IL-6, sTNFR1 with BDNF/TNF-α being significant [58].